ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

OFTHICS 200

Product Packing: 10X10

Product Composition: Ofloxacin 200 mg

Product Price: MRP : 630

OFTHICS 200 Tablets

Ofloxacin 200 mg Tablets

OFTHICS 200 is a prescription antibacterial formulation containing Ofloxacin 200 mg. Ofloxacin is a fluoroquinolone antibacterial medicine used for selected susceptible bacterial infections where its use is approved and clinically appropriate.

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for bacterial DNA replication, transcription and repair. Antibiotic selection should follow an appropriate diagnosis, approved prescribing information, local susceptibility patterns and antimicrobial-stewardship principles.

Composition

Each tablet contains:

·         Ofloxacin - 200 mg

·         Excipients - q.s.

 

Dosage form: Tablet

Pack size: 10 x 10 tablets

Uses of OFTHICS 200

OFTHICS 200 may be prescribed for selected bacterial infections caused by susceptible organisms where Ofloxacin therapy is approved and clinically appropriate.

·         Treatment of selected urinary-tract bacterial infections according to approved prescribing information

·         Treatment of selected respiratory or other bacterial infections where Ofloxacin is specifically indicated

·         Treatment of selected gastrointestinal, skin or other susceptible bacterial infections according to the approved label

·         Other approved bacterial indications as determined by the treating clinician

Ofloxacin does not treat viral infections such as the common cold or influenza. Fluoroquinolones have important safety warnings, and use should be reserved for situations where their benefits and approved indication justify the risks.

How OFTHICS 200 Works

OFTHICS 200 contains Ofloxacin, a fluoroquinolone antibacterial medicine:

DNA gyrase inhibition: Ofloxacin inhibits bacterial DNA gyrase, interfering with DNA supercoiling and replication.

Topoisomerase IV inhibition: It also inhibits topoisomerase IV, affecting separation of replicated bacterial DNA.

Bactericidal activity: These actions can lead to bacterial cell death in susceptible organisms.

Clinical response depends on infection site, organism susceptibility, dose, treatment duration and individual patient factors.

Dose selection and treatment duration must follow the approved product label and prescribing clinician's advice.

 

Dosage and Direction for Use

Use OFTHICS 200 exactly as prescribed. Dose and duration depend on the diagnosed infection, kidney function, age, clinical response and other patient factors.

Swallow the tablet with water at the time and frequency directed by the prescriber. Maintain appropriate hydration unless otherwise advised.

Do not take Ofloxacin too close to antacids, iron, zinc or other multivalent-cation products that can reduce its absorption; follow the approved label for dose separation.

Complete the prescribed course unless the treating healthcare professional advises otherwise. Renal impairment may require dose adjustment.

Possible Side Effects

Possible unwanted effects may include:

·         Nausea, diarrhoea, abdominal discomfort or vomiting

·         Headache, dizziness, insomnia or other central nervous system symptoms

·         Skin rash, itching or photosensitivity reactions can occur

·         Fluoroquinolones have important warnings including tendon inflammation or rupture, peripheral neuropathy, central nervous system effects, blood-glucose disturbances and QT-related cardiac rhythm effects

·         Seek prompt medical attention for tendon pain or swelling, new numbness or weakness, severe neurologic symptoms, severe allergy, persistent or bloody diarrhoea, fainting or significant palpitations.

Persistent or troublesome adverse effects should be discussed with the treating healthcare professional.

Precautions and Contraindications

Before using OFTHICS 200, the prescriber should review quinolone allergy, kidney function, tendon history, neurologic history, cardiac rhythm risk and all concomitant medicines. Important precautions include:

·         Do not use in patients with known hypersensitivity to Ofloxacin or other quinolone antibacterials according to approved prescribing information.

·         Fluoroquinolones can cause serious and potentially persistent adverse reactions involving tendons, muscles, joints, peripheral nerves and the central nervous system.

·         Use caution in patients with significant renal impairment because dose adjustment may be necessary.

·         Use caution in patients with QT prolongation, electrolyte abnormalities, seizure risk or myasthenia gravis according to approved prescribing information.

·         Antibiotic-associated diarrhoea, including C. difficile-associated disease, can occur during or after antibacterial treatment.

·         Pregnancy, breastfeeding, children, older adults and patients with significant chronic conditions require individualized professional guidance; fluoroquinolone use has specific age and risk considerations.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Ofloxacin absorption can be reduced by antacids and products containing aluminium, magnesium, iron, zinc or other multivalent cations when taken too closely together. Clinically relevant interactions may also involve anticoagulants, glucose-lowering medicines, QT-prolonging drugs and other therapies.

·         Patients should provide the prescriber with a complete list of prescription medicines, OTC products, vitamins, minerals and supplements before starting Ofloxacin.

Business Growth Opportunity with OFTHICS 200

OFTHICS 200 offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add an Ofloxacin 200 mg prescription antibacterial tablet to their anti-infective product portfolio.

Antibacterial therapy is an established prescription healthcare segment. Promotion and use should support antimicrobial stewardship and remain strictly consistent with approved product information and applicable pharmaceutical regulations.

 

Key Business Advantages

·         Single-ingredient fluoroquinolone antibacterial formulation

·         Ofloxacin 200 mg

·         Established fluoroquinolone antibacterial molecule

·         Convenient tablet dosage form

·         Suitable addition to anti-infective prescription portfolios where Ofloxacin use is clinically appropriate

·         Opportunity for ethical, stewardship-conscious promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for OFTHICS 200

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for OFTHICS 200 in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for OFTHICS 200 and other quality-focused healthcare products.

Third-Party Manufacturing Support for Ofloxacin 200 mg Tablets

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to OFTHICS 200 under their own brand, subject to applicable licensing, prescription-drug, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized product and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand an anti-infective prescription product portfolio.

Frequently Asked Questions About OFTHICS 200

1. What is OFTHICS 200?

OFTHICS 200 is a tablet formulation containing Ofloxacin 200 mg.

2. What is OFTHICS 200 used for?

It may be prescribed for selected susceptible bacterial infections where Ofloxacin therapy is approved and clinically appropriate.

3. How should OFTHICS 200 be taken?

Take OFTHICS 200 exactly as prescribed by a qualified healthcare professional and complete the prescribed course unless advised otherwise.

4. Can OFTHICS 200 be used for a common cold or flu?

No. Ofloxacin is an antibacterial medicine and does not treat viral infections such as the common cold or influenza.

5. Are there important tendon or nerve precautions?

Yes. Fluoroquinolones can cause serious tendon injury and peripheral neuropathy. Stop activity and seek medical advice promptly if tendon pain, swelling, numbness or weakness develops.

6. Can antacids or mineral supplements affect Ofloxacin?

Yes. Certain antacids and mineral-containing products can reduce Ofloxacin absorption when taken too closely together. Follow the prescriber's instructions on dose separation.

7. Is a PCD Pharma Franchise available for OFTHICS 200?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Ofloxacin 200 mg tablet may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

OFTHICS 200 product information in this document is for general professional and business information. Exact approved indications, dosage, contraindications, warnings, interactions, susceptibility considerations, administration instructions, monitoring requirements, treatment duration, excipients and regulatory status must be verified against the current approved product label and applicable prescribing information before prescribing, dispensing, use or promotion. Fluoroquinolone antibiotics have important safety warnings and should be used responsibly under medical supervision. This document is not a substitute for professional medical advice.

Contact